Literature DB >> 27309476

Effect of Estrogen Therapy on TNF-α and iNOS Gene Expression in Spinal Cord Injury Model.

Akram Amini Pishva1, Mohammad Akbari1, Akram Farahabadi1, Ali Arabkheradmand2, Cordian Beyer3, Nasrin Dashti4, Fatemeh Moradi1, Gholamreza Hassanzadeh1.   

Abstract

Spinal cord injury (SCI) is a crucial complication that results in neurons degeneration. The SCI lead to triggering of secondary complications such as inflammation that in turn has a key role in neurodegeneration development. The previous studies showed that TNF-α and iNOS genes expression increased significantly after SCI. As a consequence, these genes overexpression intensify the inflammation and neuron degeneration process. In the present study, 32 male Wistar rats were chased and divided into four groups of eight. The SCI were induced in three groups and another group used as a sham. The estrogen hormone used as a therapeutic agent in rats with SCI. The results showed that injection of 10 μg/kg/12h estrogen hormone reduced the TNF-α and iNOS genes expression significantly and confirmed the role of progesterone in the reduction of inflammation reduce the inflammation. The numbers of intact neurons in Estrogen group were higher than other groups and showed that progesterone has protective effects on neuron death. The BBB test was performed and demonstrated that estrogen is an effective factor in the improvement of locomotor response. Our results suggested that estrogen hormone with anti-inflammatory activity can be an efficient agent for SCI complications therapy.

Entities:  

Keywords:  Estrogen; Inducible nitric oxide synthase; Iran; Spinal cord injury; Tumor necrosis alpha

Mesh:

Substances:

Year:  2016        PMID: 27309476

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  7 in total

1.  Schwann cell transplantation exerts neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and remyelination.

Authors:  Mahboubeh Mousavi; Azim Hedayatpour; Keywan Mortezaee; Yousef Mohamadi; Farid Abolhassani; Gholamreza Hassanzadeh
Journal:  Metab Brain Dis       Date:  2019-06-04       Impact factor: 3.584

Review 2.  Hormonal therapy in traumatic spinal cord injury.

Authors:  Parker E Ludwig; Arun A Patil; Andrea J Chamczuk; Devendra K Agrawal
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

3.  Stem cells from human apical papilla decrease neuro-inflammation and stimulate oligodendrocyte progenitor differentiation via activin-A secretion.

Authors:  Amy Llyod; Pauline De Berdt; Pauline Bottemanne; John Bianco; Mireille Alhouayek; Anibal Diogenes; Jose Gerardo-Nava; Gary A Brook; Véronique Miron; Giulio G Muccioli; Anne des Rieux
Journal:  Cell Mol Life Sci       Date:  2018-02-07       Impact factor: 9.261

Review 4.  Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.

Authors:  Xin Sun; Zachary B Jones; Xiao-Ming Chen; Libing Zhou; Kwok-Fai So; Yi Ren
Journal:  J Neuroinflammation       Date:  2016-10-06       Impact factor: 8.322

5.  Lipid Peroxidation and Its Role in the Expression of NLRP1a and NLRP3 Genes in Testicular Tissue of Male Rats: a Model of Spinal Cord Injury

Authors:  Mahshid Bazrafkan; Banafsheh Nikmehr; Abdolhossein Shahverdi; Fatemeh Hassani; Mahnaz Poorhassan; Tahmineh Mokhtari; Farid Abolhassani; Hamid Choobineh; Cordian Beyer; Gholamreza Hassanzadeh
Journal:  Iran Biomed J       Date:  2017-10-16

Review 6.  Inflammation: A Target for Treatment in Spinal Cord Injury.

Authors:  Ximena Freyermuth-Trujillo; Julia J Segura-Uribe; Hermelinda Salgado-Ceballos; Carlos E Orozco-Barrios; Angélica Coyoy-Salgado
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

Review 7.  Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury.

Authors:  Angela Faccendini; Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla Marcella Caramella; Franca Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.